✦ LIBER ✦

The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor

✍ Scribed by Zhang, Wenhui; Krauwinkel, Walter J. J.; Keirns, James; Townsend, Robert W.; Lasseter, Kenneth C.; Plumb, Lisa; Kadokura, Takeshi; Ushigome, Fumihiko; Smulders, Ronald

Book ID: 121382589
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 33
Category: Article
ISSN: 1179-1918
DOI: 10.1007/s40261-013-0089-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Ipragliflozin (ASP1941), a Nov

Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects

✍ Dr Stephan A. Veltkamp, Takeshi Kadokura, Walter J. J. Krauwinkel, Ronald A. Smu 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 188 KB

The effect of mild and moderate hepatic

The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor

✍ Nenad Sarapa; Margaret R. Britto; Michelle B. Mainka; Kourosh Parivar 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 325 KB

Safety, Pharmacokinetic, and Pharmacodyn

Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus

✍ Schwartz, Sherwyn L.; Akinlade, Bola; Klasen, Sally; Kowalski, Donna; Zhang, Wen 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 322 KB

A novel sodium–glucose co-transporter 2

A novel sodium–glucose co-transporter 2 gene (SGLT2) mutation contributes to the abnormal expression of SGLT2 in renal tissues in familial renal glucosuria

✍ Yu, Lei; Hou, Ping; Lv, Ji-Cheng; Liu, Guo-Ping; Zhang, Hong 📂 Article 📅 2014 🏛 Springer Netherlands 🌐 English ⚖ 514 KB

Effects of Hydrochlorothiazide on the Ph

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

✍ Devineni, Damayanthi; Vaccaro, Nicole; Polidori, David; Rusch, Sarah; Wajs, Ewa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 437 KB

2.224 Effect of moderate hepatic impairm

2.224 Effect of moderate hepatic impairment and cigarette smoking on the pharmacokinetics of istradefylline

✍ N. Rao; P. Chaikin; B. Dvorchik; N. Sussman; A. Mori; T. Uchimura 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB